Skip to main content
Clinical Trials/NCT05200832
NCT05200832
Recruiting
Not Applicable

Impact of Long COVID-19 on the Health and Quality of Life of Military Personnel (Active or Retired) and Their Families

Direction Centrale du Service de Santé des Armées1 site in 1 country10,000 target enrollmentSeptember 5, 2022
ConditionsCOVID-19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Direction Centrale du Service de Santé des Armées
Enrollment
10000
Locations
1
Primary Endpoint
Prevalence of mental health events
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Severe and sometimes irreversible sequelae are observed in people who have developed a severe form of COVID-19 (pulmonary, cardiovascular, renal, neurological sequelae among others). More than 10% of individuals who contracted the disease, even in a mild form, still have at least one of the initial symptoms at six months, also known as prolonged symptoms or long COVID syndrome. The most frequently observed symptoms are asthenia, neurological disorders (headache, anosmia, ageusia, etc.), cardio-thoracic disorders, pain, digestive or skin disorders. Very recently, the first results of a British prospective cohort study (PHOSPCovid) indicate that more than half of the COVID-19 survivors who were hospitalised experienced a very severe to moderate deterioration in their mental and/or physical health five months after hospitalisation. Women are particularly affected. Another American study shows that 85% of non-hospitalised COVID-19 patients developed at least 4 neurological symptoms impacting their quality of life. The most common are: "brain fog" (81%), headaches (68%), numbness or tingling (60%), taste impairment (59%) and loss of smell (55%).

These disabling symptoms may persist for weeks or months, deteriorating the quality of life of patients and making it difficult for some to return to a normal life. On the basis of current knowledge concerning the long-term sequelae of SARS-CoV-2 infection, it seems necessary to offer these subjects a specific care pathway and to adapt their living and working conditions beyond their medical care.

The present study is aimed at measuring the impact of long COVID on the health and quality of life of the defence community (military personnel and their families).

Registry
clinicaltrials.gov
Start Date
September 5, 2022
End Date
September 5, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Direction Centrale du Service de Santé des Armées
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years-old
  • Be affiliated to the French military health insurance

Exclusion Criteria

  • Age \< 18 years-old

Outcomes

Primary Outcomes

Prevalence of mental health events

Time Frame: Until the end of the study (12 months)

Prevalence of mental health events will be calculated in each group, the compared: number of participants who report having experienced a mental health event (e.g. anxiety disorder) divided by the number of participants.

Study Sites (1)

Loading locations...

Similar Trials